Memorial Sloan-Kettering researchers have discovered a way that cancer cells may be able to exchange information by establishing long bridges between cells called tunneling nanotubes.

Memorial Sloan-Kettering researchers have found why certain drugs are not sufficiently effective in treating leukemias called myeloproliferative neoplasms.

Enzalutamide, a targeted therapy co-invented by a Memorial Sloan-Kettering investigator, has received FDA approval for the treatment of men with metastatic prostate cancer.

Dr. Finley, Co-Director of the Complex Airway Program, explains how he lays out a treatment plan with his patients, and determines which type of surgery fits best in the context of their lifestyle.

Dr. D’Angelica – who treats patients with liver, pancreatic, and bile duct cancers – discusses the expertise of Memorial Sloan-Kettering surgeons, who routinely perform complex procedures.

We have experts in all disciplines vital to treating esophageal cancer, and can provide therapies for people at any stage of the disease, from precancerous lesions to metastatic cancer.

Dr. Mehrara talks about the expertise of Memorial Sloan-Kettering plastic surgeons and how patients with breast cancer and head and neck cancer benefit from recent advances in reconstructive surgery.